Search - tctmd.com

Displaying 21 - 40 of 696

Sort: Relevancy | Date

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Yael L. Maxwell

May 05, 2025

LuX-Valve TTVR Device Provides Favorable 1-Year Results

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

Weekend Warriors Also See Mortality Benefits With Exercise

News Daily News

Weekend Warriors Also See Mortality Benefits With Exercise

Michael O'Riordan

April 10, 2025

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

News Conference News EHRA 2025

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

March 31, 2025

FDA Approves Tenecteplase for Acute Ischemic Stroke

News Daily News

FDA Approves Tenecteplase for Acute Ischemic Stroke

Michael O'Riordan

March 03, 2025

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

News Conference News ISC 2025

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

February 11, 2025

Lower Diagnostic Success With Transradial Cerebral Angiography

News Conference News ISC 2025

Lower Diagnostic Success With Transradial Cerebral Angiography

February 07, 2025

Sexual Minorities See Sharpest Impact of SDOH on CV Health

News Daily News

Sexual Minorities See Sharpest Impact of SDOH on CV Health

February 07, 2025

Use of Secondary CVD Prevention Meds Still Meager Worldwide

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

February 03, 2025

Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist

News Daily News

Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist

January 15, 2025

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

News Daily News

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

November 25, 2024

Two Trials Provide Insights Into Catheter Ablation Options for Persistent AF

News Conference News AHA 2024

Two Trials Provide Insights Into Catheter Ablation Options for Persistent AF

November 21, 2024

Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD

News Conference News AHA 2024

Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD

Yael L. Maxwell

November 16, 2024

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

October 30, 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

TCT 217: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Bifurcation Lesion: A Subgroup Study of FAVOR III China

Presentation TCT 2024

TCT 217: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Bifurcation Lesion: A Subgroup Study of FAVOR III China

Presenter: Lei Song

October 29, 2024

TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial

Presentation TCT 2024

TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial

Presenter: han zhang

October 29, 2024

TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial

Presentation TCT 2024

TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial

Presenter: Hao-Yu Wang

October 29, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.